Codes / ICD10CM / T65.814A

T65.814A Toxic effect of latex, undetermined, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic Effect of Latex, Undetermined, Initial Encounter (ICD-10-CM Code: T65.814A)

Summary

This condition describes adverse health effects resulting from exposure to latex, where the intent of exposure is not specified. It encompasses reactions triggered by contact with latex-containing products, and the "initial encounter" designation indicates this is the first time the patient is receiving care for this specific episode.

Causes

The toxic effect arises from exposure to latex, which can occur through direct skin contact, inhalation of airborne latex particles, or mucosal contact. Latex is commonly found in gloves, medical devices, and other products, and reactions may develop due to sensitization or immediate contact.

Risk Factors

  • Repeated exposure to latex, such as in healthcare or manufacturing settings.
  • History of allergies, particularly to other substances like certain foods (e.g., avocados, bananas).
  • Certain medical conditions, including spina bifida or urological abnormalities.
  • Use of latex-containing products without protective barriers.

Symptoms

  • Skin reactions: itching, redness, hives, or contact dermatitis.
  • Respiratory symptoms: sneezing, coughing, wheezing, or asthma-like reactions.
  • Systemic reactions: in severe cases, anaphylaxis with swelling, difficulty breathing, or shock.
  • Mucosal irritation: burning or itching in the mouth, nose, or eyes.

Diagnosis

Diagnosis relies on clinical assessment, patient history of exposure, and correlation with symptoms. Skin prick tests or blood tests for latex-specific IgE may confirm sensitivity, though results must align with the clinical presentation. The "undetermined" intent of exposure is documented based on available information at the time of encounter.

Treatment Options

Management focuses on removing the source of latex exposure and addressing symptoms. For mild reactions, antihistamines or topical corticosteroids may be used. Severe reactions, such as anaphylaxis, require immediate administration of epinephrine and supportive care. Long-term avoidance of latex is recommended to prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and the patient’s sensitivity. Mild cases typically resolve with treatment, while severe reactions may require ongoing monitoring. Follow-up care ensures symptoms are managed and latex avoidance strategies are reinforced to prevent future episodes.

Complications

Complications can include chronic dermatitis, persistent respiratory issues, or severe anaphylactic reactions. Repeated exposure may worsen sensitivity over time, increasing the risk of more severe responses in future encounters.

Lifestyle & Prevention

Avoiding latex-containing products is key to prevention. Alternatives like nitrile or vinyl gloves, and checking product labels for latex content, reduce exposure risk. Healthcare settings should use latex-free equipment when possible, and individuals with known sensitivity should carry medical alerts.

When to Seek Professional Help

Seek immediate medical attention if symptoms include difficulty breathing, swelling of the face or throat, or signs of anaphylaxis. For persistent or worsening skin reactions, or if exposure to latex is suspected, consult a healthcare provider to evaluate and manage the condition.

Tips for Medical Coders

Use T65.814A for the initial encounter of a toxic effect of latex when the intent of exposure is undetermined. Document the clinical findings, exposure history, and intent (or lack thereof) to support code assignment. Ensure the "initial encounter" designation aligns with the first episode of care for this specific reaction.

Book a walkthrough

T65.814A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.